Navigation Links
Penn State receives $27.3 million NIH grant
Date:6/14/2011

s are part of the new curriculum.

The CTSI also will create opportunities for two-way communication with members of the community to learn what progress is being made and to share their insights into which health issues biomedical researchers should study.

"The ultimate question regarding any biomedical research is whether it addresses a real need of individuals or populations," said Larry Sinoway, Penn State CTSI director and distinguished professor of medicine. "Collaboration among different fields and in partnership with the community provides the greatest opportunity for such progress."

The CTSA will have an economic impact on the central Pennsylvania region and the state as a whole. Such grants help create or maintain well-paying jobs, and promising ideas generated in the lab and proven in clinical settings lead to the creation of new biomedical companies and industries that benefit the overall economy. NIH funding of $1.4 billion to Pennsylvania in 2010 supported roughly 28,000 jobs across the state. Penn State attracts more than $100 million in NIH funding each year across its colleges and campuses.

"Already, our Penn State Clinical and Translational Science Institute (CTSI) is bringing together researchers from across the University's colleges, campuses, programs and departments, and fostering collaborative research," said Harold L. Paz, CEO of Penn State Hershey Medical Center, Penn State's senior vice dean for health affairs and dean of the Penn State College of Medicine. "This CTSA funding award will add to this momentum and substantially increase our infrastructure for supporting translational research, expanding our ability to take scientific progress from the laboratory bench to the patient's bedside."

The Penn State CTSI, founded in 2008, comprises many Penn State entities, including:

  • Penn State Hershey Medical Center
  • Penn State College of Medicine
  • College of Health and Human Develo
    '/>"/>

Contact: Megan W. Manlove
mmanlove@hmc.psu.edu
717-531-8604
Penn State
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Distracted Driving May Be Rising Despite State Laws
2. Drugs for Enlarged Prostate May Raise Risk of Aggressive Cancer
3. Drug shows promise in prostate cancer spread to bone
4. Jury Still Out on Radiation for Early Prostate Cancer
5. Targeted cancer therapy kills prostate tumor cells
6. Hormone deprivation therapy for prostate cancer may raise diabetes risk
7. ASCO: Experimental vaccine made from frozen immune cells shows promise for prostate cancer patients
8. Antifungal drug delays need for chemo in advanced prostate cancer
9. Higher doses of radiation in fewer treatments proved safe, effective for low-risk prostate cancer
10. IMRT cuts GI side effects from prostate cancer in half vs. 3D-CRT
11. Tie Between Biomarkers, Disease Often Overstated, Scientists Say
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... One of the major segments ... for implant dentistry comprises dental implants and abutments ... for dental care is bifurcated into two segments: ... segment is composed of large equipment. , View ... http://www.researchmoz.us/global-dental-market-report-2014-edition-report.html , The worldwide dental market is ...
(Date:11/27/2014)... Today, Digital-Signage-China.com adds 2 new items to its collection of ... player promotion for Dec. 2014. , The CEO of ... April, and this promotion will help to expand our customer ... on our website, she/he can contact us with special need. ... come in the latest designs, and they actually are a ...
(Date:11/27/2014)... Providenciales, Turks and Caicos Islands; BWI (PRWEB) November 28, ... earlier for the Tuscany Resort in the Turks & ... 44 resorts by TripAdvisor in Providenciales, is announcing a ... oceanfront three bedroom villa rentals. And they are ... the resort. , Additionally, The Tuscany, is having ...
(Date:11/27/2014)... 27, 2014 According to a recent ... looking to break into the surgical robotics market ... other than the MIS field dominated by Intuitive. These ... U.S. surgical robotics market by 2020. , “The ... Kamran Zamanian, CEO and President of iData. “System sales ...
(Date:11/27/2014)... Blood-borne pathogens raise the risk of ... procedures in place to counter this. However, it doesn’t ... tainted with menstrual blood are taken as seriously. ... sanitary way to handle tampons and menstrual pads while ... Calif. , He then created a prototype of the ...
Breaking Medicine News(10 mins):Health News:Dental Market Research Report 2014 - Global Industry Size, Share, Trends, Growth, Retail Sales Value and Forecast by Researchmoz.us 2Health News:Dental Market Research Report 2014 - Global Industry Size, Share, Trends, Growth, Retail Sales Value and Forecast by Researchmoz.us 3Health News:Digital-Signage-China.com Offers Big Discounts On Its New Digital Signage Media Players 2Health News:The Tuscany on Grace Bay, Top-Rated TripAdvisor Resort in the Turks & Caicos Islands, Offers Special Pre-Christmas & January 2015 Promotions! 2Health News:U.S. Robotic Surgery Market Set to Diversify and Grow: Intuitive Surgical’s ‘da Vinci’ Robot Revenues to Increasingly Rely On Procedures and Services 2
... Market for EMR and PACS to Reach $9.3 Billion by ... to a new market research report series by iData Research ... market research firm, the U.S. market for Electronic Medical Records ... to more than quadruple in value by 2013. , An ...
... is one of the most vital and dynamic sectors of ... which needs to keep pace with the evolving demands of ... , , New analysis from Frost & Sullivan ( ... Company Profiles , finds that the global medical device market ...
... ... HEALTHeCAREERS Network , ... Englewood, CO (Vocus) July 7, 2009 -- The Texas Hospital Association (THA) ... the state,s hospital members to hundreds of career Web sites., , , , ,"HEALTHeCAREERS ...
... ... Recent data from the Food and Drug Administration’s Adverse Event Reporting System ... disorders reported by users of Reglan (or its generic version, metoclopramide) more ... the manufacturers of Reglan and metoclopramide to add a black-box ...
... July 7 , - Former England ... Rob Hicks, Call on Men to Bat Away Embarrassment and Take,Appropriate ... innings of the Ashes commencing this week, celebrity TV,presenter and former ... to think about their health as well as the Ashes Test,Series ...
... PROVIDE IMMEDIATE BENEFIT TO HEART , A ... to patients. Researchers from the Feinstein Institute for ... biomarkers associated with cardiovascular disease (CVD) in "at ... showed that smoking cessation resulted in significant reductions ...
Cached Medicine News:Health News:iData Research Publishes Market Analysis Series on Electronic Medical Records and PACS 2Health News:Frost & Sullivan Identifies Innovative and Cost-Effective Technology as Key Competitive Factor in European Medical Device Market 2Health News:Frost & Sullivan Identifies Innovative and Cost-Effective Technology as Key Competitive Factor in European Medical Device Market 3Health News:Texas Hospital Association Endorses HEALTHeCAREERS Network 2Health News:Reglan Adverse Events More Than Doubled from 2006 to 2008 2Health News:Reglan Adverse Events More Than Doubled from 2006 to 2008 3Health News:Reglan Adverse Events More Than Doubled from 2006 to 2008 4Health News:Multimedia Release: British Men Think Talking About Impotence is "Just Not Cricket" 2Health News:Multimedia Release: British Men Think Talking About Impotence is "Just Not Cricket" 3Health News:Multimedia Release: British Men Think Talking About Impotence is "Just Not Cricket" 4Health News:Multimedia Release: British Men Think Talking About Impotence is "Just Not Cricket" 5Health News:News briefs from the July issue of CHEST 2
(Date:11/26/2014)... 2014  Breckenridge Pharmaceutical, Inc. announced today that ... with Pii (Pharmaceutics International, Inc.) ( Hunt ... Pii expect to develop and commercialize several new ... will develop, manufacture and supply the products, and ... its own label.  The drugs, comprised of four ...
(Date:11/26/2014)... 25, 2014 Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... presentations at two upcoming investor conferences.  , 31 ... on Tuesday, December 2, 2014 at 6:45 a.m. EST / ... head of EUSA International, will provide an overview of the company ... Annual Piper Jaffray Healthcare Conference in New York, NY ...
(Date:11/26/2014)... -- Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will ... New York on Wednesday, December 3, 2014 ... Helen Torley , President and Chief Executive Officer, will provide ... through the "Investors" section of Halozyme,s corporate website at ... 90 days following the event. To access the live webcast, ...
Breaking Medicine Technology:Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with Pharmaceutics International, Inc. 2Jazz Pharmaceuticals Announces Participation in Two Investor Conferences 2Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference 2
... IRVINE, Calif., June 12 Masimo (Nasdaq: ... Motion and Low-Perfusion pulse oximetry, announced today that three ... of Masimo PVI as a noninvasive and continuous measure ... week at the European Society of Anaesthesiology (ESA) Annual ...
... Safety and Biologic Activity Data Reviewed in End of Phase ... VIA Pharmaceuticals, Inc. (Nasdaq: VIAP ), a ... treatment of cardiovascular and metabolic disease, announced today that an ... VIA-2291 (atreleuton), was recently held with the U.S. Food and ...
Cached Medicine Technology:New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring 2New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring 3New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring 4New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring 5New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring 6VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease 2VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease 3VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease 4VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease 5
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: